News | April 20, 2012

GE Healthcare Developing Compact Cyclotron and PET Tracer System

Joint financing agreement with Sweden’s NXT2B may allow greater access to emerging and developing markets

April 20, 2012 — GE Healthcare and NXT2B, a privately owned venture capital company, announced they have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and positron emission tomography (PET) tracer production. The three-year development project will be led by GE Healthcare and will be headquartered in Uppsala, Sweden. The terms of the agreement were not disclosed.

“In line with GE’s Healthymagination strategy to develop innovations that increase access, reduce cost and improve quality in the healthcare system globally, GE Healthcare and NXT2B are pleased to announce a joint financing project to develop an unmatched next generation of equipment and software for the production of PET tracers,” said Erik Strömqvist, general manager, cyclotrons, GE Healthcare. “The goal of the project is to develop a turn-key radiotracer infrastructure solution for the production of PET tracers to primarily fulfill the needs of emerging markets, for rural and regional hospitals, and researchers.”

At the core of the new TRACERcenter 600 are a compact, cost-effective, easy-to-site cyclotron and a radiotracer production operation. The PETtrace 600 cyclotron will have an approximately 50 percent smaller footprint than a traditional cyclotron, enabling siting in settings never before possible. Together with PETtrace 600, the TRACERcenter 600 solution will be capable of producing a full portfolio of F18 and C11 tracers to detect cancer and neurodegenerative disease.

“We’re proud to partner with GE to help create greater access to PET tracer production in areas of the world that previously did not have access, and to address the large unmet needs for PET diagnostics in oncology and neurology,” said Bengt Ågerup, CEO and founder of NXT2B.

While the technology of PET scanners have rapidly developed and evolved, parallel advancements in the necessary tracer production equipment and processes have not occurred. Current PET tracer production methods are costly, complicated and require a large number of highly trained individuals. With the inherent nature of the short-lived isotopes, distribution is often not possible due to lack of supporting infrastructure in regions where PET imaging is expanding.

“Simplifying the process and technology of PET tracer production involves a paradigm shift from a traditional approach to a small, easy-to-use cyclotron, a chemistry module that is automated, and a complete and compliant quality control process that is integrated into the system,” added Stromqvist.

For more information: www.nxt2b.com, www.gehealthcare.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...